Report overview
This report contains market size and forecasts of Biomarkers for Signing Cancer in Global, including the following market information:
Global Biomarkers for Signing Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Biomarkers for Signing Cancer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Genetic Biomarkers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Biomarkers for Signing Cancer include Bristol-Myers Squibb Company, Sysmex Corporation, QIAGEN, Becton, Dickinson and Company, Agilent Technologies, Abbott Laboratories, Hologic, Quest Diagnostics and Biom?rieux SA, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biomarkers for Signing Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarkers for Signing Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, by Type, 2022 (%)
Genetic Biomarkers
Protein Biomarkers
Glyco-biomarkers
Global Biomarkers for Signing Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery and Development
Others
Global Biomarkers for Signing Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Biomarkers for Signing Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biomarkers for Signing Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biomarkers for Signing Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb Company
Sysmex Corporation
QIAGEN
Becton, Dickinson and Company
Agilent Technologies
Abbott Laboratories
Hologic
Quest Diagnostics
Biom?rieux SA
Illumina
Merck KGaA
Exact Sciences Corporation
F.Hoffmann-La Roche Ltd
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
